A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz… - Blood, 2004 - ashpublications.org
A tumor-specific, bcr-abl-derived fusion peptide vaccine can be safely administered to
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz… - Blood, 2004 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> A tumor-specific, bcr-abl-derived fusion
peptide vaccine can be safely administered to patients with chronic myelogenous leukemia …
peptide vaccine can be safely administered to patients with chronic myelogenous leukemia …
[HTML][HTML] A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz… - Blood, 2004 - Elsevier
A tumor-specific, bcr-abl-derived fusion peptide vaccine can be safely administered to
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.
K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz… - Blood, 2003 - europepmc.org
A tumor-specific, bcr-abl-derived fusion peptide vaccine can be safely administered to
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K Cathcart, J Pinilla-Ibarz, T Korontsvit, J Schwartz… - …, 2004 - pubmed.ncbi.nlm.nih.gov
A tumor-specific, bcr-abl-derived fusion peptide vaccine can be safely administered to
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
patients with chronic myelogenous leukemia (CML) and can elicit a bcr-abl peptide-specific …
[引用][C] A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K CATHCART, J PINILLA-IBARZ, T KORONTSVIT… - Blood, 2004 - pascal-francis.inist.fr
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid
leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
leukemia CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[引用][C] A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
K CATHCART - Blood, 2004 - cir.nii.ac.jp